Lv11
65 积分 2021-06-08 加入
Multidrug-resistant Gram-negative bacterial infections
1小时前
已完结
OS-030 Efficacy and safety of xalnesiran with and without an immunomodulator in virologically suppressed participants with chronic hepatitis B: end of study results from the phase 2, randomized, controlled, adaptive, open-label platform study (PIRANGA)
4个月前
已完结
皖公网安备34019202002308
